Why Nostr? What is Njump?
2025-04-13 23:06:59
in reply to

feeds.guardian.co.uk on Nostr: feeds.guardian.co.uk ✍️ The NHS in England is launching a trial for a new cancer ...



✍️ The NHS in England is launching a trial for a new cancer vaccine, iSCIB1+, which helps the immune system recognize cancer cells and respond to immunotherapy treatment.
👉 The NHS is launching a trial for a new cancer vaccine, iSCIB1+, in England
👉 The vaccine helps the immune system recognize cancer cells and respond to immunotherapy treatment
👉 The trial is part of the NHS England's Cancer Vaccine Launch Pad program
👉 The program aims to provide 10,000 patients with personalized cancer treatments by 2030
👉 Patients with advanced skin melanoma will be given fast-track access to the trial

#ProfPeterJohnson #KeirStarmer #SusannaDaniels #England #UK #health


NHS Cancer Vaccine Launch Pad expanded to include trial for patients with advanced type of skin cancerPatients with an advanced type of skin melanoma in England will be given fast-track access to a “revolutionary” new cancer vaccine as part of an NHS trial.The vaccine, known as iSCIB1+ (ImmunoBody), helps the immune system recognise cancer cells and therefore better respond to immunotherapy treatment. Continue reading...
https://www.theguardian.com/society/2025/apr/14/melanoma-patients-in-england-get-fast-track-access-to-cancer-vaccine

Author Public Key
npub1veec6wv460ucwnmwa9kdl43d3vhgwnv8cj5eju6tsl95uthn8s9sckhyrj